The Latest Breaking News from Central Drugs Standard Control Organisation

5 Reasons Two Generic Drugs With the Same Name Behave Differently

Pick up the same generic drug from two different manufacturers and the strip looks nearly identical: same active ingredient, same stated dose, same approved indication. Yet doctors in India regularly hear patients report that one brand of amlodipine controls their blood pressure and another does not, or that one generic…

Times Life · 2h ago

Dr Reddy’s Q2 Results: Net profit falls 36% YoY to Rs 913 crore, revenue declines marginally

Dr Reddy’s Laboratories reported a 36% year-on-year profit decline to Rs 913.4 crore in Q2 FY27, while revenue slipped 1.5%. North America weakness pressured performance, offset partly by growth in India and emerging markets, alongside biosimilar approvals and strategic partnerships.

The Economic Times · Oct 23

Sanofi healthcare receives CDSCO approval for Qftilia therapy for haemophilia patients in India

Sanofi Healthcare has obtained authorisation from the Central Drugs Standard Control Organisation for Qfitlia. This therapy is designed to prevent bleeding in haemophilia patients aged 12 years and older. Qfitlia offers unique protection for Haemophilia A and B patients, requiring only six injections annually. The approval follows promising results from…

The Economic Times · Oct 21